Pharming secures €10 million working capital facility from existing investors
03:08 EDT 1 Aug 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
Leiden, The Netherlands, August 1, 2012. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has secured an equity working capital facility of up to €10 million for a two y...
Other Sources for this Article
More From BioPortfolio on "Pharming secures €10 million working capital facility from existing investors"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
